Chantal M Boulanger1. 1. INSERM U970, Paris Cardiovascular Research Center-PARCC, Paris, France. Chantal.boulanger@inserm.fr
Abstract
PURPOSE OF REVIEW: To summarize the potential role of microparticles in hypertension and in cardiovascular diseases. Microparticles are submicron vesicles shed from the membrane in response to cell activation or apoptosis. Microparticles of different cellular origins are found in the plasma of healthy individuals and their circulating levels augment in patients with cardiovascular diseases. RECENT FINDINGS: Recent studies demonstrate that circulating levels of microparticles originating from endothelial cells, which represent a small fraction of the overall pool of plasma microparticles, augment with increased endothelial dysfunction in patients with cardiovascular diseases. Therefore, endothelial microparticles constitute an emerging surrogate marker of endothelial dysfunction, with potential prognostic value for major adverse events in patients with cardiovascular diseases. In addition, microparticles of endothelial and other cellular origins are also potential biological effectors in inflammation, vascular injury, angiogenesis and thrombosis. SUMMARY: In summary, circulating endothelial microparticles may serve not only as an index of arterial damage but also as a trigger of vascular repair.
PURPOSE OF REVIEW: To summarize the potential role of microparticles in hypertension and in cardiovascular diseases. Microparticles are submicron vesicles shed from the membrane in response to cell activation or apoptosis. Microparticles of different cellular origins are found in the plasma of healthy individuals and their circulating levels augment in patients with cardiovascular diseases. RECENT FINDINGS: Recent studies demonstrate that circulating levels of microparticles originating from endothelial cells, which represent a small fraction of the overall pool of plasma microparticles, augment with increased endothelial dysfunction in patients with cardiovascular diseases. Therefore, endothelial microparticles constitute an emerging surrogate marker of endothelial dysfunction, with potential prognostic value for major adverse events in patients with cardiovascular diseases. In addition, microparticles of endothelial and other cellular origins are also potential biological effectors in inflammation, vascular injury, angiogenesis and thrombosis. SUMMARY: In summary, circulating endothelial microparticles may serve not only as an index of arterial damage but also as a trigger of vascular repair.
Authors: Merriline M Satyamitra; Andrea L DiCarlo; Brynn A Hollingsworth; Thomas A Winters; Lanyn P Taliaferro Journal: Radiat Res Date: 2022-05-01 Impact factor: 3.372
Authors: Carmine Savoia; Lidia Sada; Luigi Zezza; Lorenzo Pucci; Francesco Maria Lauri; Alberto Befani; Alessandro Alonzo; Massimo Volpe Journal: Int J Hypertens Date: 2011-09-11 Impact factor: 2.420
Authors: Dylan Burger; Dylan G Kwart; Augusto C Montezano; Naomi C Read; Christopher R J Kennedy; Charlie S Thompson; Rhian M Touyz Journal: J Am Heart Assoc Date: 2012-06-22 Impact factor: 5.501
Authors: Gaëlle Gonzalez; Cyrielle Vituret; Attilio Di Pietro; Marc Chanson; Pierre Boulanger; Saw-See Hong Journal: PLoS One Date: 2012-12-20 Impact factor: 3.240